Company news

Xenetic Biosciences, Inc. news in 2021

Xenetic Biosciences, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Xenetic Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update

November 11, 2021

Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent

September 8, 2021

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

September 7, 2021

Xenetic Biosciences, Inc. Reports Second Quarter 2021 Financial Results and Provides Business Update

August 12, 2021

Xenetic Biosciences, Inc. Announces Closing of $12.5 Million Private Placement Priced at a Premium to Market

July 27, 2021

Xenetic Biosciences, Inc. Announces $12.5 Million Private Placement Priced at a Premium to Market

July 25, 2021

Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results

May 11, 2021

Xenetic Biosciences, Inc. to Present at the Q2 Virtual Investor Summit

May 9, 2021

Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM)

March 28, 2021

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

March 2, 2021

Xenetic Biosciences, Inc. Announces Partner's Filing of Registration Dossier in Russia for Epolong Product Candidate That Utilizes Xenetic's PolyXen(R) Platform Technology

February 15, 2021

Xenetic Biosciences, Inc. to Present at NobleCon17

January 13, 2021

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright BioConnect 2021 Virtual Conference

January 4, 2021

Decks in 2021